Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Nkarta, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- +5 vs. Q3 2021
- Shares held
- 23.9M
- +467.0K (+2.0%) vs. Q3 2021
- Total value
- $366.5M
- −$284.8M (−43.7%) vs. Q3 2021
- New holders
- 23
- 28 more added
- Sold out
- 18
- 23 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 126 | $121.6M |
| Q4 2025 | 119 | $103.2M |
| Q3 2025 | 120 | $119.4M |
| Q2 2025 | 104 | $96.9M |
| Q1 2025 | 111 | $113.2M |
| Q4 2024 | 112 | $154.8M |
| Q3 2024 | 119 | $301.7M |
| Q2 2024 | 112 | $391.5M |
| Q1 2024 | 115 | $687.1M |
| Q4 2023 | 94 | $270.2M |
| Q3 2023 | 85 | $50.7M |
| Q2 2023 | 97 | $86.5M |
| Q1 2023 | 100 | $147.0M |
| Q4 2022 | 121 | $251.9M |
| Q3 2022 | 105 | $561.5M |
| Q2 2022 | 115 | $536.7M |
| Q1 2022 | 84 | $287.2M |
| Q4 2021 | 92 | $366.5M |
| Q3 2021 | 87 | $651.4M |
| Q2 2021 | 89 | $764.7M |
| Q1 2021 | 97 | $866.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Nkarta, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −8,838−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −7,777−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −7,243−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −5,320−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,933−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,366−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −755−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |